Harrow, Inc. SEC filings HROW

Harrow, Inc. has 868 filings in SEC EDGAR's recent list, going back to Jul 21, 2006. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 2, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
10-K Annual report Mar 8, 2021 Dec 31, 2020
10-K Annual report Mar 13, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018
10-K Annual report Mar 8, 2018 Dec 31, 2017
10-K Annual report Mar 21, 2017 Dec 31, 2016
10-K Annual report Mar 23, 2016 Dec 31, 2015
10-K Annual report Mar 12, 2015 Dec 31, 2014
10-K/A Amended annual report Apr 30, 2014 Dec 31, 2013
10-K Annual report Mar 28, 2014 Dec 31, 2013
10-K Annual report Mar 18, 2013 Dec 31, 2012
10-K Annual report Feb 23, 2012 Dec 31, 2011
10-K Annual report Feb 23, 2012 Dec 31, 2010
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 26, 2009 Dec 31, 2008

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HROW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Nashville, TN
SEC filer status
Large accelerated filer
SEC CIK
1360214
Former names
HARROW HEALTH, INC. (until Sep 20, 2023); Imprimis Pharmaceuticals, Inc. (until Dec 17, 2018); TRANSDEL PHARMACEUTICALS INC (until Feb 27, 2012); Bywater Resources, Inc (until Sep 12, 2007)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.